IN8bio, Inc. (INAB) Misses Q4 EPS by 1c

IN8bio, Inc. (NASDAQ: INAB) reported Q4 EPS of ($0.08), $0.01 worse than the analyst estimate of ($0.07).

For earnings history and earnings-related data on IN8bio, Inc. (INAB) click here.

You May Also Be Interested In

• RXO shares soar as C.H. Robinson announces $5.8B cash and stock buyout
• AMD (AMD) PT Raised to $700 at Stifel on Expectation of Beat-And-Raise Results
• Goldman Sachs: 'Semiconductors: SIA data shows mostly above-seasonal trends in August'